Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

PhD Damijan Knez

PhD Damijan Knez
no.: 36438 source: ARIS

researcher – active in research organisation
damijan.knezat signffa.uni-lj.si
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Keywords
medicinal chemistry, enzyme inhibitors, drug design, Alzheimer's disease
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Evaluation (rules)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
763.58
A''
167.89
A'
473.3
A1/2
659.65
CI10
1,334
CImax
106
h10
22
A1
2.91
A3
0
Data for the last 5 years (citations for the last 10 years) on April 25, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 67  1,434  1,259  18.79 
Scopus 69  1,514  1,323  19.17 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
2nd cycle master's degree  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2013 
Doctor's degree  Ph. D.   Biomedicine  SI University of Ljubljana, Faculty of Pharmacy 2017 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position ecris.org.employ_rolegroup Title
Full time employment (100%, RD:100%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  10/1/2013  Assistant  Researcher  Lecturer 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J1-50023  3DfluorCO - Three-dimensional fluorine-based carbonyl bioisosteres: asymmetric synthesis and validation   2023 - 2024  PhD Andrej Emanuel Cotman  1,045 
2. J1-50037  Development of CDK1-selective degraders for the treatment of T-cell malignancies   2023 - 2024  PhD Izidor Sosič  1,093 
3. N1-0277  Research of multifunctional compounds targeting neuroinflammation and cholinergic deficit in Alzheimer's disease   2023 - 2024  PhD Stanislav Gobec  1,060 
4. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   2022 - 2024  PhD Matej Sova  3,919 
5. BI-FR/23-24-PROTEUS-002  Development of effective reactivators of organophosphate-inhibited butyrylcholinesterase   2023 - 2024  PhD Damijan Knez  198 
6. J3-3071  Cathepsins B and X in breast cancer stem cells – molecular targets and relevance for antitumor therapy   2021 - 2024  PhD Ana Mitrović  2,653 
7. L1-3160  Development of highly concentrated protein formulations and evaluation of absorption kinetics after subcutaneous administration   2021 - 2024  PhD Iztok Grabnar  2,929 
8. J1-3018  Smart probes for ex vivo assay-based early prediction of Alzheimer disease   2021 - 2024  PhD Janez Košmrlj  2,196 
9. BI-US/22-24-004  Optimization of selective butyrylcholine esterase inhibitors as potential therapeutic agents for heroin abuse therapy   2022 - 2024  PhD Damijan Knez  198 
10. N1-0169  Kovalentni pristop k boju proti bakterijski rezistenci (Slovene)   2021 - 2023  PhD Stanislav Gobec  1,180 
11. Z1-1859  Targeted covalent inhibitors: inhibiting monoamine oxidase through non-catalytic amino-acid residues   2019 - 2021  PhD Damijan Knez  198 
12. J1-8145  Dynamic aspect of ligand-protein binding   2017 - 2020  PhD Simona Golič Grdadolnik  1,749 
13. J3-9267  Inhibition of cathepsin X activity as a novel strategy for the treatment of Parkinson's disease   2018 - 2019  PhD Anja Pišlar  2,723 
14. J1-9192  New anticancer leads for emerging cancer target potassium ion channels hEag1 and its validation in lymphoma tumors   2018 - 2019  PhD Lucija Peterlin Mašič  2,195 
15. N1-0068  Identification of non-peptidic inhibitors of the immunoproteasome using fragment based drug discovery methods   2017 - 2019  PhD Stanislav Gobec  1,803 
16. J4-8227  Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy   2017 - 2019  PhD Janko Kos  4,553 
17. L1-8157  Development of multifunctional compounds for treatment of Alzheimer's disease   2017 - 2019  PhD Stanislav Gobec  4,690 
18. J1-8152  Inhibition of Staphylococcus aureus cell wall remodeling   2017 - 2019  PhD Dušan Turk  1,976 
19. J1-7479  Structural insight into iodine metabolism   2018  PhD Dušan Turk  1,765 
20. L1-6745  Combating bacterial resistance: optimisation of bacterial cell wall biosynthesis inhibitors   2014 - 2016  PhD Stanislav Gobec  3,233 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   2022 - 2024  PhD Stanislav Gobec  5,312 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   2015 - 2021  PhD Stanislav Gobec  5,974 
3. P1-0208  Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)   2013 - 2014  PhD Danijel Kikelj  5,847 
Confirmation required
Views history
Favourite